skip to Main Content
Valiant Laboratories IPO

Valiant Laboratories IPO GMP Listing Today, Pricing, GMP, Analysis, And Insights

Open A/C With Alice Blue

Most Popular FnO Broker

Flat ₹15 Per Trade

Valiant Laboratories is gearing up for its IPO, scheduled to open on September 27, 2023, and conclude on October 3, 2023. The IPO aims to raise approximately ₹152 crores through the issuance of 11,556,000 equity shares at a face value of ₹10 each. The allocation for this IPO includes 35% for retail investors, 50% for Qualified Institutional Buyers (QIBs), and 15% for High Net Worth Individuals (HNIs).

Open Demat A/C With Zerodha

Free Eq Delivery & MF

Flat ₹20 Per Trade

 

Company Profile

Valiant Laboratories is a manufacturer of Active Pharmaceutical Ingredients (APIs) or Bulk Drugs, with a primary focus on Paracetamol. APIs are essential raw materials used in the production of finished dosage forms. Paracetamol, a widely consumed analgesic, is endorsed by the World Health Organization (WHO) as a first-line therapy for various pain conditions. It finds applications in the treatment of headaches, muscle aches, arthritis, toothaches, colds, and fever. Valiant Laboratories manufactures Paracetamol in different grades, including IP/BP/EP/USP, in compliance with the pharmacopeia requirements of their clients.

The company operates its manufacturing facility in Tarapur Industrial Area, Palghar, Maharashtra, India, spanning approximately 2,000 sq. mts. and boasting an annual installed capacity of 9,000 MT. The facility is equipped with modern machinery and equipment to ensure efficient operations. Valiant Laboratories holds certifications for good manufacturing practices (GMP) and ISO 9001:2015, attesting to its commitment to quality. A dedicated quality control team oversees the entire manufacturing process, from raw material testing to final product inspection before packaging.

Within the same facility, Valiant Laboratories has an in-house Research and Development (R&D) infrastructure, furnished with an analytical laboratory and facilities for product development activities. The company attributes its enduring customer relationships to its emphasis on research and development, adherence to regulatory standards, robust quality systems, and continuous process enhancements.

Valiant Laboratories IPO GMP

Company NameIPO PriceGMP(₹ %)Status
Mandeep Auto Industries670 (0.0%)Upcoming
Refractory Shapes318 (25.81%)Upcoming
Finelistings Technologies12320 (16.26%)Upcoming
Winsol Engineers75124 (165.33%)Upcoming
Indegene452263 (58.19%)Upcoming
Slone Infosystems6740 (59.7%)Available for Apply
Sai Swami Metals6045 (75%)Closed (Listing Awaited)
Racks & Rollers7835 (44.87%)Closed (Listing Awaited)
Amkay Products5545 (81.82%)Closed (Listing Awaited)
Emmforce Autotech98130 (132.65%)Listed @186.20 (90.00%)
Shivam Chemicals442 (4.55%)Listed @48.00 (9.09%)
Varyaa Creations1500 (0%)Listed @285.00 (90.00%)
JNK India415135 (32.53%)Listed @621.00 (49.64%)
Faalcon Concepts625 (8.06%)Listed @ 95 (53.23%)
VI FPOClose 111.4 (12.73%)Listed @ 11.80 (7.27%)
Grill Splendour Services1208 (6.67%)Listed @ 121.30 (1.08%)
Ramdevbaba Solvent859 (10.59%)Listed @ 112.00 (31.76%)
Greenhitech Ventures5012 (24%)Listed @95.00 (90.00%)
DCG Cables10025 (25%)Listed @90.00 (-10.00%)
Teerth Gopicon1113 (2.7%)Listed @125.00 (12.61%)

 

IPO Objectives

The proceeds from the IPO will be utilized for the following purposes:

  1. Investment in Valiant Advanced Sciences Private Limited (VASPL), their whollyowned subsidiary, for financing capital expenditures related to setting up a specialty chemicals manufacturing facility at Saykha Industrial Area, Bharuch, Bharuch, Gujarat (Proposed Facility).
  2. Investment in VASPL for funding its working capital requirements.
  3. General corporate purposes.

 

Key IPO Details

  • IPO Open Date: September 27, 2023
  • IPO Close Date: October 3, 2023
  • IPO Size: Approximately ₹152 Crores
  • Fresh Issue: Approximately 11,556,000 shares
  • Face Value: ₹10 Per Equity Share
  • IPO Price Band: ₹133 to ₹140 Per Share
  • IPO Listing on: BSE & NSE
  • Retail Quota: 35%
  • QIB Quota: 50%
  • NII Quota: 15%

 

IPO Timeline

  • IPO Open Date: September 27, 2023
  • IPO Close Date: October 3, 2023
  • Basis of Allotment: October 6, 2023
  • Refunds: October 9, 2023
  • Credit to Demat Account: October 10, 2023
  • IPO Listing Date: October 11, 2023

 

Valiant Laboratories IPO Grey Market Premium GMP:

 

How to Apply for Valiant Laboratories IPO

Investors can apply for Valiant Laboratories IPO via ASBA (Applications Supported by Blocked Amount) online through their bank accounts, through UPI via their stockbrokers, or offline by filling out the IPO forms.

 

Financial Performance (in Crores)

  • 2021: Revenue ₹183.78, Expense ₹136.75, Profit (PAT) ₹30.59
  • 2022: Revenue ₹293.47, Expense ₹251.76, Profit (PAT) ₹27.49
  • 2023: Revenue ₹338.77, Expense ₹300.63, Profit (PAT) ₹28.99

 

Valuation  FY2023

  • Earnings Per Share (EPS): ₹8.91 per Equity Share
  • Price/Earnings (P/E) Ratio: N/A
  • Return on Net Worth (RoNW): 28.86%
  • Net Asset Value (NAV): ₹30.86 per Equity Share

 

Company Promoters

  • Shantilal Shivji Vora
  • Dhanvallabh Ventures LLP

 

IPO Registrar

Link Intime India Private Limited

Phone: +91 8108114949

Email: valiantlaboratories.ipo@linkintime.co.in

Website: https://linkintime.co.in

 

IPO Allotment Status Check

  • Check Valiant Laboratories IPO allotment status on the Link Intime website.

 

IPO Lead Managers (Merchant Bankers)

  • Unistone Capital Private Limited

 

Company Address

Valiant Laboratories Limited

104, Udyog Kshetra, Mulund Goregaon Link Road,

Mulund West,

Mumbai  400080, Maharashtra

Phone: +91 2249712001

Email: complianceofficer@valiantlabs.in

Website: www.valiantlabs.in

Valiant Laboratories IPO FAQs

What is Valiant Laboratories IPO?

Valiant Laboratories IPO is a main-board IPO. They are going to raise ₹152 Crores via IPO. The issue is priced at ₹133 to ₹140 pr equity share. The IPO is to be listed on BSE & NSE.

When Valiant Laboratories IPO will open?

The IPO is to open on September 27, 2023 for QIB, NII, and Retail Investors.

What is Valiant Laboratories IPO Investors Portion?

The investors’ portion for QIB is 50%NII is 15%, and Retail is 35%.

How to Apply the Valiant Laboratories IPO?

You can apply for Valiant Laboratories IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.

How to Apply Valiant Laboratories IPO through Zerodha?

For those using Zerodha, the application process involves logging into the Zerodha Console, selecting the IPO under the Portfolio section, and then filling in the necessary details. Approval through a UPI app is also required. Opening a Demat Account with Zerodha may be necessary for some applicants. Open Demat Account with Zerodha.

How to Apply the Valiant Laboratories IPO through Alice Blue?

Alice Blue users can apply by logging into the Alice Blue application, selecting the IPO, and confirming their application. Similar to other methods, approval via a UPI app is required. Opening a Demat Account with Alice Blue may also be necessary. Open a Demat Account with Alice Blue.

How to Apply for the Valiant Laboratories IPO through Motilal Oswal?

Log in to Motilal Oswal Application with your credentials. Select the IPO. You will see the IPO Name. Click on the Bid Button. Confirm your application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Motilal Oswal.

What is Valiant Laboratories IPO Size?

Valiant Laboratories IPO size is ₹152 crores.

What is Valiant Laboratories IPO Price Band?

Valiant Laboratories IPO Price Band is ₹133 to ₹140.

What is the Valiant Laboratories IPO Allotment Date?

Valiant Laboratories IPO allotment date is October 6, 2023.

What is the Valiant Laboratories IPO Listing Date?

Valiant Laboratories IPO listing date is October 11, 2023. The IPO is to list on BSE and NSE.

Related Articles

The views and investment tips expressed by experts on kunjcapital.com are their own and not those of the website or its management. Kunjcapital.com advises users to check with certified experts before making any investment decisions. *Services related to Advisory on Kunjcapital.com are not running by kunjcapital.com and they are proposed services, Sebi Registration Awaited.

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top